drugset / Trial / NCT01893905

Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis

NCT01893905

Phase 3 Completed 158 enrolled Tedec-Meiji Farma, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main objective is to assess the efficacy of a new formulation containing chondroitin sulfate and glucosamine sulfate (CS+GS) compared with placebo in patients with primary osteoarthritis of the knee.

Timeline

Start
2013-06
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulfate Unknown 1200 mg Oral
Subject Glucosamine Small molecule 1500 mg Oral

Indications